Abstract
The review summarizes the results of studies on the cellular and molecular mechanisms mediating the impact of stress on the pathogenesis of neurodegenerative brain pathologies (Alzheimer’s disease, Parkinson’s disease, etc.) and presents current information on the role of stress in the hyperphosphorylation of tau protein, aggregation of beta‑amyloid, and hyperactivation of the hypothalamic-pituitary-adrenal axis involved in the hyperproduction of factors that contribute to the pathogenetic role of stress in neurodegeneration. The data on the participation of microglia in the effects of stress on the pathogenesis of neurodegenerative diseases are presented.
Similar content being viewed by others
Abbreviations
- Aβ:
-
amyloid beta
- AD:
-
Alzheimer’s disease
- ALS:
-
amyotrophic lateral sclerosis
- BDNF:
-
brain-derived neurotrophic factor
- GC:
-
glucocorticoid
- CSs:
-
corticosteroid
- CRH:
-
corticotropin-releasing hormone
- CRHR:
-
CRH receptor
- HD:
-
Huntington’s disease
- HPA axis:
-
hypothalamic-pituitary-adrenal axis
- PD:
-
Parkinson’s disease
References
Kolanowski, A., Boltz, M., Galik, E., Gitlin, L. N., Kales, H. C., et al. (2017) Determinants of behavioral and psychological symptoms of dementia: a scoping review of the evidence, Nurs. Outlook, 65, 515-529, https://doi.org/10.1016/j.outlook.2017.06.006.
Ross, J. A., Gliebus, G., and Van Bockstaele, E. J. (2017) Stress induced neural reorganization: a conceptual framework linking depression and Alzheimer’s disease, Prog. Neuropsychopharmacol. Biol. Psychiatry, 85, 136-151, https://doi.org/10.1016/j.pnpbp.2017.08.004.
Donley, G. A. R., Lönnroos, E., Tuomainen, T. P., and Kauhanen, J. (2018) Association of childhood stress with late-life dementia and Alzheimer’s disease: the KIHD study, Eur. J. Public Health, 28, 1069-1073, https://doi.org/10.1093/eurpub/cky134.
Peña-Bautista, C., Casas-Fernández, E., Vento, M., Baquero, M., and Cháfer-Pericás, C. (2020) Stress and neurodegeneration, Clin. Chim. Acta, 503, 163-168, https://doi.org/10.1016/j.cca.2020.01.019.
Liu, Y. Z., Wang, Y. X., and Jiang, C. L. (2017) Inflammation: the common pathway of stress-related diseases, Front. Hum. Neurosci., 11, 316, https://doi.org/10.3389/fnhum.2017.00316.
Lopes, S., Vaz-Silva, J., Pinto, V., Dalla, C., Kokras, N., et al. (2016) Tau protein is essential for stress-induced brain pathology, Proc. Natl. Acad. Sci. USA, 113, E3755-E3763, https://doi.org/10.1073/pnas.1600953113.
Lopes, S., Teplytska, L., Vaz-Silva, J., Dioli, C., Trindade, R., et al. (2017) Tau deletion prevents stress-induced dendritic atrophy in prefrontal cortex: role of synaptic mitochondria, Cerebr. Cortex, 27, 2580-2591.
Arendt, T., Stieler, J. T., and Holzer, M. (2016) Tau and tauopathies, Brain Res. Bull., 126, 238-292, https://doi.org/10.1016/j.brainresbull.2016.08.018.
Sierra-Fonseca, J. A., and Gosselink, K. L. (2018) Tauopathy and neurodegeneration: a role for stress, Neurobiol. Stress, 9, 105-112, https://doi.org/10.1016/j.ynstr.2018.08.009.
Stephens, M. A., and Wand, G. (2012) Stress and the HPA axis: role of glucocorticoids in alcohol dependence, Alcohol. Res., 34, 468-483.
Gulyaeva, N. V. (2019) Biochemical mechanisms and translational relevance of hippocampal vulnerability to distant focal brain injury: the price of stress response, Biochemistry (Moscow), 84, 1306-1328, https://doi.org/10.1134/S0006297919110087.
Sotiropoulos, I., and Sousa, N. (2016) Tau as the converging protein between chronic stress and Alzheimer’s disease synaptic pathology, Neurodegener. Dis., 16, 22-25, https://doi.org/10.1159/000440844.
Yi, J. H., Brown, C., Whitehead, G., Piers, T., Lee, Y. S., et al. (2017) Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus, Pharmacol. Res., 121, 42-51, https://doi.org/10.1016/j.phrs.2017.04.015.
Lesuis, S. L., Maurin, H., Borghgraef, P., Lucassen, P. J., Van Leuven, F., and Krugers, H. J. (2016) Positive and negative early life experiences differentially modulate long term survival and amyloid protein levels in a mouse model of Alzheimer’s disease, Oncotarget, 7, 39118-39135, https://doi.org/10.18632/oncotarget.9776.
Justice, N. J., Huang, L., Tian, J. B., Cole, A., Pruski, M., et al. (2015) Posttraumatic stress disorder-like induction elevates beta-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses, J. Neurosci., 35, 2612-2623, https://doi.org/10.1523/JNEUROSCI.3333-14.2015.
Cuadrado-Tejedor, M., and García-Osta, A. (2016) Chronic mild stress assay leading to early onset and propagation of Alzheimer’s disease phenotype in mouse models, Methods Mol. Biol., 1303, 241-246, https://doi.org/10.1007/978-1-4939-2627-5_14.
Han, B., Yu, L., Geng, Y., Shen, L., Wang, H., et al. (2016) Chronic stress aggravates cognitive impairment and suppresses insulin associated signaling pathway in APP/PS1 mice, J. Alzheimer’s Dis., 53, 1539-1552, https://doi.org/10.3233/JAD-160189.
Hoeijmakers, L., Ruigrok, S. R., Amelianchik, A., Ivan, D., van Dam, A. M., et al. (2017) Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer’s disease mouse model, Brain Behav. Immun., 63, 160-175, https://doi.org/10.1016/j.bbi.2016.12.023.
Justice, N. J. (2018) The relationship between stress and Alzheimer’s disease, Neurobiol. Stress, 8, 127-133, https://doi.org/10.1016/j.ynstr.2018.04.002.
Han, B., Wang, J. H., Geng, Y., Shen, L., Wang, H. L., et al. (2017) Chronic stress contributes to cognitive dysfunction and hippocampal metabolic abnormalities in APP/PS1 mice, Cell. Physiol. Biochem., 41, 1766-1776, https://doi.org/10.1159/000471869.
Mietelska-Porowska, A., Wasik, U., Goras, M., Filipek, A., and Niewiadomska, G. (2014) Tau protein modifications and interactions: their role in function and dysfunction, Int. J. Mol. Sci., 15, 4671-4713, https://doi.org/10.3390/ijms15034671.
Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., et al. (2016) Microglia development follows a stepwise program to regulate brain homeostasis, Science, 353, aad8670, https://doi.org/10.1126/science.aad8670.
Tian, L., Hui, C. W., Bisht, K., Tan, Y., Sharma, K., et al. (2017) Microglia under psychosocial stressors along the aging trajectory: consequences on neuronal circuits, behavior, and brain diseases, Prog. Neuropsychopharmacol., Biol. Psychiatry, 79 (Pt. A), 27-39, https://doi.org/10.1016/j.pnpbp.2017.01.007.
Cartier, N., Lewis, C.-A., Zhang, R., and Rossi, F. M. V. (2014) The role of microglia in human disease: therapeutic tool or target? Acta Neuropathol., 128, 363-380, https://doi.org/10.1007/s00401-014-1330-y.
Derecki, N. C., Katzmarski, N., Kipnis, J., and Meyer-Luehmann, M. (2014) Microglia as a critical player in both developmental and late-life CNS pathologies, Acta Neuropathol., 128, 333-345, https://doi.org/10.1007/s00401-014-1321-z.
Sipe, G. O., Lowery, R. L., Tremblay, M.-È., Kelly, E. A., Lamantia, C. E., and Majewska, A. K. (2016) Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex, Nat. Commun., 7, 10905, https://doi.org/10.1038/ncomms10905.
Ransohoff, R. M., and El Khoury, J. (2015) Microglia in health and disease, Cold Spring Harb. Perspect. Biol., 8, a020560, https://doi.org/10.1101/cshperspect.a020560.
Tay, T. L., Savage, J. C., Hui, C. W., Bisht, K., and Tremblay, M.-È. (2017) Microglia across the lifespan: from origin to function in brain development, plasticity and cognition, J. Physiol., 595, 1929-1945, https://doi.org/10.1113/JP272134.
Chun, H., Marriott, I., Lee, C. J., Cho, H. (2018) Elucidating the interactive roles of glia in Alzheimer's disease using established and newly developed experimental models, Front. Neurol., 26, 797, https://doi.org/10.3389/fneur.2018.00797.
Santos, L. E., Beckman, D., and Ferreira, S. T. (2016) Microglial dysfunction connects depression and Alzheimer’s disease, Brain Behav. Immun., 55, 151-165, https://doi.org/10.1016/j.bbi.2015.11.011.
Piirainen, S., Youssef, A., Song, C., Kalueff, A. V., Landreth, G. E., et al. (2017) Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer’s disease: the emerging role for microglia? Neurosci. Biobehav. Rev., 77, 148-164, https://doi.org/10.1016/j.neubiorev.2017.01.046.
Milior, G., Lecours, C., Samson, L., Bisht, K., Poggini, S., et al. (2016) Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress, Brain Behav. Immun., 55, 114-125, https://doi.org/10.1016/j.bbi.2015.07.024.
Hellwig, S., Brioschi, S., Dieni, S., Frings, L., Masuch, A., et al. (2016) Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice, Brain Behav. Immun., 55, 126-137, https://doi.org/10.1016/j.bbi.2015.11.008.
Rimmerman, N., Schottlender, N., Reshef, R., Dan-Goor, N., and Yirmiya, R. (2017) The hippocampal transcriptomic signature of stress resilience in mice with microglial fractalkine receptor (CX3CR1) deficiency, Brain Behav. Immun., 61, 184-196, https://doi.org/10.1016/j.bbi.2016.11.023.
Winkler, Z., Kuti, D., Ferenczi, S., Gulyás, K., Polyák, Á., and Kovács, K. J. (2017) Impaired microglia fractalkine signaling affects stress reaction and coping style in mice, Behav. Brain Res., 334, 119-128, https://doi.org/10.1016/j.bbr.2017.07.023.
Dong, H., Goico, B., Martin, M., Csernansky, C. A., Bertchume, A., and Csernansky, J. G. (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress, Neuroscience, 127, 601-609, https://doi.org/10.1016/j.neuroscience.2004.05.040.
Chiba, S., Numakawa, T., Ninomiya, M., Richards, M. C., Wakabayashi, C., and Kunugi, H. (2012) Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex, Prog. Neuropsychopharmacol. Biol. Psychiatry, 39, 112-119, https://doi.org/10.1016/j.pnpbp.2012.05.018.
Roth, T. L., Zoladz, P. R., Sweatt, J. D., and Diamond, D. M. (2011) Epigenetic modification of hippocampal BDNF DNA in adult rats in an animal model of post-traumatic stress disorder, J. Psychiatr. Res., 45, 919-926, https://doi.org/10.1016/j.jpsychires.2011.01.013.
Michalski, B., and Fahnestock, M. (2003) Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s disease, Mol. Brain Res., 111, 148-154, https://doi.org/10.1016/s0169-328x(03)00003-2.
Peng, S., Wuu, J., Mufson, E. J., and Fahnestock, M. (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease, J. Neurochem., 93, 1412-1421, https://doi.org/10.1111/j.1471-4159.2005.03135.x.
Fonken, L. K., Frank, M. G., Gaudet, A. D., and Maier, S. F. (2018) Stress and aging act through common mechanisms to elicit neuroinflammatory priming, Brain. Behav. Immun., 73, 133-148, https://doi.org/10.1016/j.bbi.2018.07.012.
Schouten, M., Bielefeld, P., Garcia-Corzo, L., Passchier, E. M. J., Gradari, S., et al. (2019) Circadian glucocorticoid oscillations preserve a population of adult hippocampal neural stem cells in the aging brain, Mol. Psychiatry, 25, 1382-1405, https://doi.org/10.1038/s41380-019-0440-2.
Kvetnansky, R., Novak, P., Vargovic, P., Lejavova, K., Horvathova, L., Ondicova, K., et al. (2016) Exaggerated phosphorylation of brain tau protein in CRH KO mice exposed to repeated immobilization stress, Stress, 19, 395-405, https://doi.org/10.1080/10253890.2016.1183119.
Huang, C.-C., Chung, C.-M., Leu, H.-B., Lin, L.-Y., Chiu, C.-C., et al. (2014) Diabetes mellitus and the risk of Alzheimer’s disease: a nationwide population-based study, PLoS One, 9, e87095, https://doi.org/10.1371/journal.pone.0087095.
Rojas-Gutierrez, E., Muñoz-Arenas, G., Treviño, S., Espinosa, B., Chavez, R., et al. (2017) Alzheimer’s disease and metabolic syndrome: a link from oxidative stress and inflammation to neurodegeneration, Synapse, 71, e21990, https://doi.org/10.1002/syn.21990.
Singh-Manoux, A., Dugravot, A., Fournier, A., Abell, J., Ebmeier, K., et al. (2017) Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study, JAMA Psychiatry, 74, 712-718, https://doi.org/10.1001/jamapsychiatry.2017.0660.
Rogalska, J. (2010) Mineralocorticoid and glucocorticoid receptors in hippocampus: their impact on neurons survival and behavioral impairment after neonatal brain injury, Vitam. Horm., 82, 391-419, https://doi.org/10.1016/S0083-6729(10)82020-5.
Yau, J. L. W., Noble, J., and Seckl, J. R. (2011) 11b-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control, J. Neurosci., 31, 4188-4193, https://doi.org/10.1523/JNEUROSCI.6145-10.2011.
Li, Y., Qin, J., Yan, J., Zhang, N., Xu, Y., et al. (2019) Differences of physical vs. psychological stress: evidences from glucocorticoid receptor expression, hippocampal subfields injury, and behavioral abnormalities, Brain Imaging Behav., 13, 1780-1788, https://doi.org/10.1007/s11682-018-9956-3.
McEwen, B. S. (1997) Possible mechanisms for atrophy of the human hippocampus, Mol. Psychiatry, 2, 255-262, https://doi.org/10.1038/sj.mp.4000254.
Sousa, N., Madeira, M. D., and Paula-Barbosa, M. M. (1998) Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study, Brain Res., 794, 199-210, https://doi.org/10.1016/S0006-8993(98)00218-2.
Sousa, N., Lukoyanov, N. V., Madeira, M. D., Almeida, O. F. X., and Paula-Barbosa, M. M. (2000) Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement, Neuroscience, 97, 253-266, https://doi.org/10.1016/S0306-4522(00)00050-6.
Woolley, C. S., Gould, E., and McEwen, B. S. (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons, Brain Res., 531, 225-231, https://doi.org/10.1016/0006-8993(90)90778-A.
Pereda-Pérez, I., Valencia, A., Baliyan, S., Núñez, Á., Sanz-García, A., et al. (2019) Systemic administration of a fibroblast growth factor receptor 1 agonist rescues the cognitive deficit in aged socially isolated rats, Neurobiol. Aging, 78, 155-165, https://doi.org/10.1016/j.neurobiolaging.2019.02.011.
Zimmerman, M. E., Ezzati, A., Katz, M. J., Lipton, M. L., Brickman, A. M., et al. (2016) Perceived stress is differentially related to hippocampal subfield volumes among older adults, PLoS One, 11, 154530, https://doi.org/10.1371/journal.pone.0154530.
Moreno-Jiménez, E. P., Flor-García, M., Terreros-Roncal, J., Rábano, A., Cafini, F., et al. (2019) Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease, Nat. Med., 25, 554-560, https://doi.org/10.1038/s41591-019-0375-9.
Ho, R. T. H., Fong, T. C. T., Yau, J. C. Y., Chan, W. C., Kwan, J. S. K., et al. (2020) Diurnal cortisol slope mediates the association between affect and memory retrieval in older adults with mild cognitive impairment: a pathanalytical study, Front. Aging Neurosci., 12, 35, https://doi.org/10.3389/fnagi.2020.00035.
Davis, K. L., Davis, B. M., Greenwald, B. S., Mohs, R. C., Mathé, A. A., et al. (1986) Cortisol and Alzheimer’s disease, I: basal studies, Am. J. Psychiatr., 143, 300-305, https://doi.org/10.1176/ajp.143.3.300.
Hartmann, A., Veldhuis, J. D., Deuschle, M., Standhardt, H., and Heuser, I. (1997) Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation, Neurobiol. Aging, 18, 285-289, https://doi.org/10.1016/s0197-4580(97)80309-0.
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., et al. (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits, Nat. Neurosci., 1, 69-73, https://doi.org/10.1038/271.
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., et al. (2006) Plasma cortisol and progression of dementia in subjects with Alzheimer type dementia, Am. J. Psychiatry, 163, 2164-2169, https://doi.org/10.1176/ajp.2006.163.12.2164.
Lebedeva, A. K., Westman, E., Borza, T., Beyer, M. K., Engedal, K., et al. (2017) MRI-Based classification models in prediction of mild cognitive impairment and dementia in late-life depression, Front. Aging Neurosci., 9, 13, https://doi.org/10.3389/fnagi.2017.00013.
Mah, L., Binns, M. A., and Steffens, D. C. (2015) Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer’s disease, Am. J. Geriatr. Psychiatry, 23, 466-476, https://doi.org/10.1016/j.jagp.2014.10.005.
Starkstein, S., Dragovic, M., Brockman, S., Wilson, M., Bruno, V., and Merello, M. (2015) The impact of emotional distress on motor blocks and festination in Parkinson’s disease, J. Neuropsychiatry Clin. Neurosci., 27, 121-126, https://doi.org/10.1176/appi.neuropsych.13030053.
Kim, S. R., Kim, J. Y., Kim, H. K., Lim, K. E., Kim, M. S., and Chung, S. J. (2017) Association among type D personality, non-motor symptoms, and quality of life in Parkinson’s disease: a cross-sectional study, Geriatr. Nurs., 38, 431-436, https://doi.org/10.1016/j.gerinurse.2017.02.006.
Ibrahimagic, O. C., Jakubovic, A. C., Smajlovic, D., Dostovic, Z., Kunic, S., Iljazovic, A. (2016) Psychological stress and changes of hypothalamic-pituitary-adrenal axis in patients with “De Novo” Parkinson’s disease, Med. Arch., 70, 445-448, https://doi.org/10.5455/medarh.016.70.445-448.
Chan, Y. E., Bai, Y. M., Hsu, J. W., Huang, K. L., Su, T. P., et al. (2017) Post-traumatic stress disorder and risk of Parkinson’s disease: a nationwide longitudinal study, Am. J. Geriatr. Psychiatry, 25, 917-923, https://doi.org/10.1016/j.jagp.2017.03.012.
Blakemore, R. L., MacAskill’, M. R., Shoorangiz, R., and Anderson, T. J. (2018) Stress-evoking emotional stimuli exaggerate deficits in motor function in Parkinson’s disease, Neuropsychologia, 112, 66-76, https://doi.org/10.1016/j.neuropsychologia.2018.03.006.
Zhang, Z., Chu, S. F., Wang, S. S., Jiang, Y. N., Gao, Y., et al. (2018) RTP801 is a critical factor in the neurodegeneration process of A53T α-synuclein in a mouse model of Parkinson’s disease under chronic restraint stress, Br. J. Pharmacol., 175, 590-605, https://doi.org/10.1111/bph.14091.
Wu, Q., Yang, X., Zhang, Y., Zhang, L., and Feng, L. (2016) Chronic mild stress accelerates the progression of Parkinson’s disease in A53T α-synuclein transgenic mice, Exp. Neurol., 285, Pt A, 61-71, https://doi.org/10.1016/j.expneurol.2016.09.004.
Dallé, E., and Mabandla, M. V. (2018) Early life stress, depression and Parkinson’s disease: a new approach, Mol. Brain, 11, 18, https://doi.org/10.1186/s13041-018-0356-9.
Grigoruţă, M., Martínez-Martínez, A., Dagda, R. Y., and Dagda, R. K. (2020) Psychological stress phenocopies brain mitochondrial dysfunction and motor deficits as observed in a parkinsonian rat model, Mol. Neurobiol., 57, 1781-1798, https://doi.org/10.1007/s12035-019-01838-9.
Kong, H., Yang, L., He, C., Zhou, J. W., Li, W. Z., et al. (2019) Chronic unpredictable mild stress accelerates lipopolysaccharide-induced microglia activation and damage of dopaminergic neurons in rats, Pharmacol. Biochem. Behav., 179, 142-149, https://doi.org/10.1016/j.pbb.2019.01.004.
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf, Nature, 430, 213-218, https://doi.org/10.1038/nature02664.
De Pablos, R. M., Herrera, A. J., Espinosa-Oliva, A. M., Sarmiento, M., Muñoz, M. F., et al. (2014) Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation, J. Neuroinflammation, 11, 34, https://doi.org/10.1186/1742-2094-11-34.
Sugama, S., Sekiyama, K., Kodama, T., Takamatsu, Y., Takenouchi, T., et al. (2016) Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: possible role of chronic stress in the onset of Parkinson’s disease, Brain Behav. Immun., 51, 39-46, https://doi.org/10.1016/j.bbi.2015.08.015.
Dufour, B. D., and McBride, J. L. (2016) Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington’s disease, Exp. Neurol., 283, Pt. A, 308-317, https://doi.org/10.1016/j.expneurol.2016.06.028.
Mo, C., Renoir, T., and Hannan, A. J. (2014) Effects of chronic stress on the onset and progression of Huntington’s disease in transgenic mice, Neurobiol. Dis., 71, 81-94, https://doi.org/10.1016/j.nbd.2014.07.008.
Scarpa, J. R., Jiang, P., Losic, B., Readhead, B., Gao, V. D., et al. (2016) Systems genetic analyses highlight a TGFβ-FOXO3 dependent striatal astrocyte network conserved across species and associated with stress, sleep, and Huntington’s disease, PLoS Genet., 12, e1006137, https://doi.org/10.1371/journal.pgen.1006137.
Longinetti, E., Mariosa, D., Larsson, H., Almqvist, C., Lichtenstein, P., et al. (2017) Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age, Eur. J. Neurol., 24, 137-142, https://doi.org/10.1111/ene.13165.
Parkin Kullmann, J. A., Hayes, S., and Pamphlett, R. (2018) Is psychological stress a predisposing factor for amyotrophic lateral sclerosis (ALS)? An online international case-control study of premorbid life events, occupational stress, resilience and anxiety, PLoS One, 13, e0204424, https://doi.org/10.1371/journal.pone.0204424.
Rabkin, J., Goetz, R., Murphy, J. M., Factor-Litvak, P., Mitsumoto, H., and ALS COSMOS Study Group (2016) Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort, Neurology, 87, 1320-1328, https://doi.org/10.1212/WNL.0000000000003035.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The author declares no conflict of interests. No description of studies with human subjects or animals performed by the author is provided in the paper.
Rights and permissions
About this article
Cite this article
Khaspekov, L.G. Current Views on the Role of Stress in the Pathogenesis of Chronic Neurodegenerative Diseases. Biochemistry Moscow 86, 737–745 (2021). https://doi.org/10.1134/S0006297921060110
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297921060110